Yahoo Suche Web Suche

Anmelden

Suchergebnisse

  1. Suchergebnisse:

  1. Videos

    Alle anzeigen

  2. www.mountsinai.org › about › newsroomAltering Cellular Interactions Around Amyloid Plaques May Offer...

    Vor 3 Tagen · Researchers at the Icahn School of Medicine at Mount Sinai have made a significant breakthrough in Alzheimer’s disease research by identifying a novel way to potentially slow down or even halt disease progression. The study, which focuses on the role of reactive astrocytes and the plexin-B1 protein in Alzheimer's pathophysiology, provides crucial insights into brain cell communication and ...

  3. www.nejm.org › doi › fullZodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed ...

    Vor einem Tag · Dr. Rosenson can be contacted at [email protected] or at the Metabolism and Lipids Program, Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl ...

  4. www.eurekalert.org › news-releases › 1045861Altering cellular interactions around amyloid | EurekAlert!

    Vor 3 Tagen · The Icahn School of Medicine at Mount Sinai is internationally renowned for its outstanding research, educational, and clinical care programs. It is the sole academic partner for the eight- member ...

  5. www.newsweek.com › alzheimers-breakthrough-halt-diseaseAlzheimer's Breakthrough Could Halt Progression - Newsweek

    Vor einem Tag · In a new study published in the journal Nature Neuroscience, researchers from the Icahn School of Medicine at Mount Sinai in New York have demonstrated that this enhanced cerebral scrubdown can be ...

  6. www.news-medical.net › news › 20240527Researchers identify novel way to potentially slow down or halt...

    Vor 3 Tagen · May 27 2024 Mount Sinai Health System. Researchers at the Icahn School of Medicine at Mount Sinai have made a significant breakthrough in Alzheimer's disease research by identifying a novel way to ...

  7. www.bionity.com › de › newsVeränderung der zellulären Interaktionen um Amyloid-Plaques...

    Vor einem Tag · Dr. Hongyan Zou, Professor für Neurochirurgie und Neurowissenschaften am Icahn Mount Sinai und einer der Hauptautoren der Studie, wies auf die weiterreichenden Auswirkungen der Ergebnisse hin: "Unsere Studie eröffnet neue Wege für die Alzheimer-Forschung und unterstreicht die Bedeutung der zellulären Interaktionen bei der Entwicklung von Therapien für neurodegenerative Erkrankungen."

  8. ascopubs.org › doi › 10Indirect comparison of linvoseltamab versus teclistamab for...

    Vor einem Tag · 7560 Background: No head-to-head clinical trials have compared effectiveness of anti-BCMA×CD3 bispecific antibodies for TCE RRMM. This analysis compared efficacy of linvoseltamab vs teclistamab via an unanchored matching-adjusted indirect comparison (MAIC). Methods: A MAIC was deemed feasible after excluding 10 patients (pts) with prior BCMA antibody–drug conjugate exposure from LINKER-MM1 ...